Summary

The global blood pressure cuffs market was valued at an estimated USD 909 million in 2024 and is projected to reach USD 1,399 million by 2029, at a CAGR of 9.0% during the forecast period. Growth in the market is primarily driven by the increasing prevalence of cardiovascular diseases, advancements in blood pressure monitoring, and increasing awareness of early diagnosis. As the population grows, the prevalence of hypertension and other cardiovascular diseases increases, and the demand for blood pressure monitoring devices increases The population over 65 years of age is growing at a faster rate than the younger population 65 years, according to World Population Prospects 2022 it is anticipated that the proportion of people over 65 in the world will increase from 10% in 2022 to 16% in 2050.
"The automated segment accounted for the highest CAGR of the blood pressure cuffs market in 2023, by type."
Based on type, the blood pressure cuffs market is segmented into automated and manual. Automated devices are routinely used by healthcare professionals for office/clinic and 24-hour ambulatory BP monitoring. Health care providers frequently use automated devices for office/hospital and 24-hour ambulatory BP monitoring. Automated blood pressure cuffs stand out in the BP cuff market over manual blood pressure cuffs due to their easy-to-use design that requires minimal training, easy communication and monitoring of health care systems health, and providing comfortable measurements. The growth of the automated segment is driven by the rising prevalence of hypertension and the increased adoption of home blood pressure monitoring.
"The 19 cm and above segment is projected to witness the highest growth rate in the blood pressure cuffs market, by size, during the forecast period."
The blood pressure cuffs market is segmented into 8-19 cm and 19 cm & above. Accurate BP measurement is essential for the proper diagnosis and management of hypertension, expensive R&D costs incurred by players in clinical settings and through self-measured blood pressure (SMBP) monitoring, is anticipated that the development of new technologies such as wireless cuffs will also help the segments growth in the coming years.
"The reusable segment accounted for the largest market share of blood pressure cuffs market, in 2023, by usage."
Based on usage, the blood pressure cuffs market is segmented into reusable and disposable. The large share of this segment is attributed to the large healthcare institutions, such as hospitals and nursing homes, find reusable cuffs more economical over time due to the reduced need for frequent replacements, initiatives to reduce medical waste, and policies and guidelines promoting the use of sustainable medical products support the adoption of reusable blood pressure cuffs.
"The adults segment accounted for the largest market share of blood pressure cuffs market, in 2023, by age group."
Based on age group, the blood pressure cuffs market is segmented into adults and infants & children. The large share of this segment is attributed to factors like unhealthy diets, sedentary lifestyles, stress, and increasing obesity rates in adults and children that contribute to the high prevalence of hypertension, necessitating regular monitoring and management of blood pressure.
"The offline segment accounted for the largest market share of blood pressure cuffs market, in 2023, by distribution channel."
Based on the distribution channel, the blood pressure cuffs market is segmented into offline and online. The large share of this segment is attributed to the increasing adoption of advanced blood pressure monitoring devices, the availability of blood pressure cuffs in pharmacies and retail stores, and supportive government initiatives, such as public health campaigns, subsidies, and favorable reimbursement policies for hypertension management.

"The homecare segment is projected to witness the highest growth rate in the blood pressure cuffs market, by end-user, during the forecast period."
Based on end user, the blood pressure cuffs market is segmented into hospitals, clinics, homes and other end users. The high growth rate of this segment is attributed to the convenience of monitoring blood pressure at home rather than making frequent visits to healthcare facilities, and innovations in blood pressure monitoring technology, such as automated cuffs, have made these devices more user-friendly and accurate, this has led to an increased preference for home-use blood pressure monitoring devices.

"The Asia Pacific region is projected to witness the highest growth rate in the blood pressure cuffs market during the forecast period."
The global blood pressure cuffs market is segmented into six regions - North America, Europe, Latin America, Asia Pacific, the Middle East & Africa, and the GCC Countries. The Asia Pacific market, which comprises Japan, India, China, and the Rest of Asia Pacific, is expected to offer significant growth opportunities to market players and is projected to register the highest CAGR in the blood pressure cuffs market during the forecast period. Government efforts to increase awareness about early disease diagnosis and regular health checkups, rising healthcare expenditure, and the increasing number of hospitals and clinical diagnostic laboratories, and growing awareness regarding the hypertension prevalence are some of the major factors driving the growth of the blood pressure cuffs market in the Asia Pacific.

The primary interviews conducted for this report can be categorized as follows:

• By Company Type: Tier 1 - 40%, Tier 2 - 30%, and Tier 3 - 30%
• By Designation: C-level - 27%, D-level - 18%, and Others - 55%
• By Region: North America – 35%, Europe – 26%, Asia Pacific – 24%, Latin America – 12%, Middle East & Africa – 1%, and the GCC Countries – 2%
Lists of Companies Profiled in the Report:
Omron Corporation, Inc. (Japan), Baxter International Inc. (US), Koninklijke Philips N.V. (Netherlands), GE HealthCare (US), McKesson Corporation. (US), B Braun Melsungen AG (Germany), Halma plc (UK), OSI Systems, Inc. (US), American Diagnostic Corporation (US), Medline Industries, LP. (US), Microlife Corporation (Switzerland), BIOS Medical (UK), Accoson (UK), CellBios (India), Midmark Corporation (US), Withings (France), Spengler Holtex Group (France), Beurer (Germany), Technicuff (US), W.A. Baum Co., Inc. (US), BPL Medical Technologies (India), Boen Healthcare Co. Ltd (China), and Masimo (US).

Research Coverage:
In this report, the blood pressure cuffs market has been categorized based on type (automated, and manual), size (8-19 cm, and 19 cm & above), usage (reusable, and disposable) age group (adults, and infants & children) distribution channel (offline, and online) end user (hospitals, clinics, home care, and other end users), and region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa, and the GCC Countries).
The report's coverage includes comprehensive details about the key factors impacting the growth of the blood pressure cuffs market, including opportunities, challenges, opportunities, and restraints. To offer insights into their business overview, services offered, significant strategies, acquisitions and partnerships, and recent developments related to the blood pressure cuffs market, a thorough analysis of the major industry players has been conducted. This study examines the competitive landscape of emerging blood pressure cuffs startups.

Reasons to buy this report:
The report will help market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall blood pressure cuffs market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, challenges, trends, and opportunities.
The report provides insights on the following pointers:
• Analysis of key drivers: (The increasing incidence of hypertension and cardiovascular diseases attributable to high blood pressure, and the increasing geriatric population prone to hypertension and related health conditions, and increased use of single-patient-use blood pressure cuffs to prevent hospital-acquired infections and Focus on Patient Safety and Accuracy), challenges (miscuffing or selecting an inappropriate cuff size, errors by physician- or health professional and technical limitations and accuracy issues), opportunities (The increasing adoption of advanced blood pressure monitoring devices (wireless blood pressure cuffs), and the rise of telehealth and remote patient monitoring services), and restraints (The availability of alternative methods and devices for monitoring blood pressure, lack of awareness about hypertension and the importance of regular blood pressure monitoring, and increasing transmission of HAI's due to reusable cuffs) influencing the growth of the in blood pressure cuffs market.
• Product Development/Innovation: Detailed insights on research & development activities and new product launches in the blood pressure cuffs market.
• Market Development: Comprehensive information about lucrative markets – the report analyses the blood pressure cuffs market across varied regions.
• Market Diversification: Exhaustive information about untapped geographies, recent developments, and investments in the blood pressure cuffs market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players like Omron Corporation, Inc. (Japan), Baxter International Inc. (US), and McKesson Corporation (US), among others, in the blood pressure cuffs market strategies.

ページTOPに戻る

Table of Contents

1 INTRODUCTION 25
1.1 STUDY OBJECTIVES 25
1.2 MARKET DEFINITION 25
1.2.1 INCLUSIONS & EXCLUSIONS 26
1.3 STUDY SCOPE 27
1.3.1 MARKETS COVERED 27
1.3.2 YEARS CONSIDERED 28
1.4 CURRENCY CONSIDERED 28
1.5 STAKEHOLDERS 28
1.6 RECESSION IMPACT 28
2 RESEARCH METHODOLOGY 29
2.1 RESEARCH DATA 29
2.1.1 SECONDARY DATA 30
2.1.1.1 Key data from secondary sources 31
2.1.2 PRIMARY DATA 31
2.1.2.1 Key primary participants 32
2.1.2.2 Key data from primary sources 32
2.1.2.3 Key industry insights 33
2.1.2.4 Breakdown of interviews with experts 34
2.2 MARKET SIZE ESTIMATION 35
2.2.1 BOTTOM-UP APPROACH 35
2.2.2 TOP-DOWN APPROACH 38
2.3 DATA TRIANGULATION 39
2.4 MARKET SHARE EVALUATION 40
2.5 RESEARCH ASSUMPTIONS 40
2.6 GROWTH FORECAST 40
2.7 RESEARCH LIMITATIONS 40
2.7.1 METHODOLOGY-RELATED LIMITATIONS 41
2.7.2 SCOPE-RELATED LIMITATIONS 41
2.8 RISK ASSESSMENT 41
2.9 RECESSION IMPACT 41
3 EXECUTIVE SUMMARY 43
4 PREMIUM INSIGHTS 48
4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN BLOOD PRESSURE CUFFS MARKET 48
4.2 ASIA PACIFIC: BLOOD PRESSURE CUFFS MARKET, BY TYPE AND COUNTRY 49
4.3 BLOOD PRESSURE CUFFS MARKET, BY KEY COUNTRY 50
4.4 BLOOD PRESSURE CUFFS MARKET, REGIONAL MIX (2024–2029) 50
4.5 BLOOD PRESSURE CUFFS MARKET, DEVELOPED VS. EMERGING ECONOMIES 51
5 MARKET OVERVIEW 52
5.1 INTRODUCTION 52
5.2 MARKET DYNAMICS 52
5.2.1 DRIVERS 53
5.2.1.1 Increasing incidence of hypertension and cardiovascular diseases attributable to high blood pressure 53
5.2.1.2 Rise in elderly population prone to hypertension and related
health conditions 54
5.2.1.3 Surge in use of single-patient-use blood pressure cuffs to prevent hospital-acquired infections 54
5.2.2 RESTRAINTS 55
5.2.2.1 Availability of alternative methods and devices for monitoring
blood pressure 55
5.2.2.2 Lack of hypertension awareness and need for regular
blood pressure monitoring 55
5.2.2.3 Increasing transmission of healthcare-associated infections
due to reusable cuffs 56
5.2.3 OPPORTUNITIES 57
5.2.3.1 Rising adoption of advanced blood pressure monitoring devices 57
5.2.3.2 Rising demand for telehealth and remote patient monitoring services 57
5.2.4 CHALLENGES 58
5.2.4.1 Miscuffing or selecting an inappropriate cuff size 58
5.2.4.2 Technical limitations and accuracy issues 59
5.2.4.3 Errors by physician or health professional 60
5.3 PRICING ANALYSIS 61
5.3.1 PRICING ANALYSIS, BY REGION 61
5.3.2 PRICING ANALYSIS, BY PRODUCT 62
5.4 VALUE CHAIN ANALYSIS 62
5.5 SUPPLY CHAIN ANALYSIS 63
5.6 ECOSYSTEM ANALYSIS 64
5.7 PORTER’S FIVE FORCES ANALYSIS 67
5.7.1 THREAT OF NEW ENTRANTS 68
5.7.2 THREAT OF SUBSTITUTES 68
5.7.3 BARGAINING POWER OF SUPPLIERS 68
5.7.4 BARGAINING POWER OF BUYERS 68
5.7.5 INTENSITY OF COMPETITIVE RIVALRY 69
5.8 REGULATORY LANDSCAPE 69
5.8.1 NORTH AMERICA 69
5.8.1.1 US 69
5.8.1.2 Canada 71
5.8.2 EUROPE 71
5.8.3 ASIA PACIFIC 72
5.8.3.1 Japan 72
5.8.3.2 Australia 73
5.8.3.3 Latin America 73
5.8.4 REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 74
5.9 TECHNOLOGY ANALYSIS 75
5.9.1 KEY TECHNOLOGY 75
5.9.1.1 Oscillometric 75
5.9.2 COMPLEMENTARY TECHNOLOGY 76
5.9.2.1 Auscultatory 76
5.9.3 ADJACENT TECHNOLOGY 76
5.9.3.1 Palpatory 76
5.10 TRADE ANALYSIS 77
5.10.1 IMPORT SCENARIO 77
5.10.2 EXPORT SCENARIO 77
5.11 PATENT ANALYSIS 78
5.11.1 LIST OF MAJOR PATENTS 79
5.12 KEY CONFERENCES & EVENTS IN 2024–2025 79
5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 80
5.14 KEY STAKEHOLDERS & BUYING CRITERIA 81
5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS 81
5.14.2 BUYING CRITERIA 81
5.15 INVESTMENTS AND FUNDING SCENARIO 82
6 BLOOD PRESSURE CUFFS MARKET, BY TYPE 83
6.1 INTRODUCTION 84
6.2 AUTOMATED 84
6.2.1 GROWING USE IN AMBULATORY MONITORING AND HOME BLOOD PRESSURE MEASUREMENT TO DRIVE MARKET 84
6.3 MANUAL 87
6.3.1 USE AS STANDARD DEVICE FOR ACCURATE BLOOD PRESSURE MEASUREMENT TO FUEL MARKET GROWTH 87
7 BLOOD PRESSURE CUFFS MARKET, BY SIZE 91
7.1 INTRODUCTION 92
7.2 8–19 CM 92
7.2.1 RISE IN OBESITY AMONG CHILDREN AND ADOLESCENTS TO DRIVE DEMAND 92
7.3 19 CM AND ABOVE 95
7.3.1 INCREASING PREVALENCE OF HYPERTENSION AMONG ADULTS TO
FUEL DEMAND 95
 
8 BLOOD PRESSURE CUFFS MARKET, BY USAGE 99
8.1 INTRODUCTION 100
8.2 REUSABLE 100
8.2.1 LOW COST AND HIGH DURABILITY ASSOCIATED WITH REUSABLE
BLOOD PRESSURE CUFFS TO DRIVE DEMAND 100
8.3 DISPOSABLE 102
8.3.1 PRESSING NEED FOR REDUCING TRANSMISSION OF
HEALTHCARE-ASSOCIATED INFECTIONS TO DRIVE DEMAND 102
9 BLOOD PRESSURE CUFFS MARKET, BY AGE GROUP 106
9.1 INTRODUCTION 107
9.2 ADULTS 107
9.2.1 RISING PREVALENCE OF HYPERTENSION AMONG ADULTS AND NEED FOR CHRONIC DISEASE MANAGEMENT TO DRIVE DEMAND 107
9.3 INFANTS & CHILDREN 110
9.3.1 GROWING NEED FOR EARLY DETECTION AND MANAGEMENT OF
PEDIATRIC HYPERTENSION TO FUEL DEMAND 110
10 BLOOD PRESSURE CUFFS MARKET, BY DISTRIBUTION CHANNEL 114
10.1 INTRODUCTION 115
10.2 OFFLINE 115
10.2.1 DEVELOPMENT AND EXPANSION OF HEALTHCARE CENTERS AND DISTRIBUTION NETWORKS TO DRIVE MARKET 115
10.3 ONLINE 118
10.3.1 INCREASED ACCESS TO WIDE RANGE OF PRODUCTS FOR PATIENTS FROM RURAL OR REMOTE AREAS TO DRIVE MARKET 118
11 BLOOD PRESSURE CUFFS MARKET, BY END USER 121
11.1 INTRODUCTION 122
11.2 HOSPITALS 122
11.2.1 ABILITY TO HANDLE HIGH INSTALLATION COSTS RELATED TO BLOOD PRESSURE MONITORING DEVICES TO DRIVE MARKET 122
11.3 CLINICS 125
11.3.1 EASY ACCESSIBILITY OF CLINICS AND AVAILABILITY OF TRAINED PROFESSIONALS TO DRIVE MARKET 125
11.4 HOMECARE 128
11.4.1 ACCESSIBILITY OF PERSONAL BLOOD PRESSURE MONITORS FOR MANAGING HEALTH OUTSIDE CLINICAL SETTINGS TO DRIVE DEMAND 128
11.5 OTHER END USERS 131
12 BLOOD PRESSURE CUFFS MARKET, BY REGION 135
12.1 INTRODUCTION 136
12.2 NORTH AMERICA 136
12.2.1 RECESSION IMPACT 140
 
12.2.2 US 140
12.2.2.1 Prevalence of hypertension and need for blood pressure monitoring devices to drive market 140
12.2.3 CANADA 143
12.2.3.1 Aging demography and government initiatives for cardiovascular disease prevention to boost demand for cuffs 143
12.3 EUROPE 146
12.3.1 RECESSION IMPACT 149
12.3.2 GERMANY 149
12.3.2.1 Well-developed healthcare system and stringent regulations for medical device industry to drive market 149
12.3.3 UK 152
12.3.3.1 Growing incidence of hypertension and well-established healthcare infrastructure to drive market 152
12.3.4 FRANCE 155
12.3.4.1 Surveillance and measures to mitigate risk of infectious diseases to boost demand 155
12.3.5 ITALY 158
12.3.5.1 Increasing healthcare expenditure to drive market 158
12.3.6 SPAIN 160
12.3.6.1 Government efforts to improve healthcare infrastructure to
fuel demand 160
12.3.7 REST OF EUROPE 163
12.4 ASIA PACIFIC 166
12.4.1 RECESSION IMPACT 170
12.4.2 JAPAN 170
12.4.2.1 Growing elderly population and well-developed healthcare system to drive market 170
12.4.3 CHINA 173
12.4.3.1 Rising number of hospitals and increasing prevalence of cardiovascular diseases to boost market 173
12.4.4 INDIA 176
12.4.4.1 Advanced policy initiatives and substantial medical device investments to boost domestic production of cuffs 176
12.4.5 REST OF ASIA PACIFIC 178
12.5 LATIN AMERICA 181
12.5.1 RECESSION IMPACT 184
12.5.2 BRAZIL 185
12.5.2.1 Surge in chronic conditions to boost demand for blood pressure monitoring devices 185
12.5.3 MEXICO 187
12.5.3.1 Increasing demand for advanced medical equipment to drive market 187
12.5.4 REST OF LATIN AMERICA 190
 
12.6 MIDDLE EAST & AFRICA 193
12.6.1 INCREASING PREVALENCE OF CARDIOVASCULAR DISEASES TO
PROPEL MARKET 193
12.6.2 RECESSION IMPACT 194
12.7 GCC COUNTRIES 197
12.7.1 RECESSION IMPACT 200
13 COMPETITIVE LANDSCAPE 201
13.1 OVERVIEW 201
13.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 201
13.3 REVENUE ANALYSIS, 2021–2023 203
13.4 MARKET SHARE ANALYSIS, 2023 204
13.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 206
13.5.1 STARS 206
13.5.2 EMERGING LEADERS 206
13.5.3 PERVASIVE PLAYERS 206
13.5.4 PARTICIPANTS 206
13.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 208
13.5.5.1 Company footprint 208
13.5.5.2 Usage footprint 208
13.5.5.3 Age group footprint 209
13.5.5.4 End user footprint 210
13.5.5.5 Region footprint 210
13.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 211
13.6.1 PROGRESSIVE COMPANIES 211
13.6.2 RESPONSIVE COMPANIES 211
13.6.3 DYNAMIC COMPANIES 211
13.6.4 STARTING BLOCKS 212
13.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023 213
13.6.5.1 List of key startups/SMEs 213
13.7 COMPANY VALUATION AND FINANCIAL METRICS 213
13.8 BRAND/PRODUCT COMPARISON ANALYSIS 215
13.9 COMPETITIVE SCENARIO AND TRENDS 216
13.9.1 DEALS 216
13.9.2 EXPANSIONS 216
14 COMPANY PROFILES 217
14.1 KEY PLAYERS 217
14.1.1 OMRON CORPORATION 217
14.1.1.1 Business overview 217
14.1.1.2 Products offered 219
 
14.1.1.3 MnM view 219
14.1.1.3.1 Key strengths 219
14.1.1.3.2 Strategic choices 219
14.1.1.3.3 Weaknesses/Competitive threats 220
14.1.2 BAXTER INTERNATIONAL INC. 221
14.1.2.1 Business overview 221
14.1.2.2 Products offered 222
14.1.2.3 Recent developments 223
14.1.2.3.1 Deals 223
14.1.2.4 MnM view 223
14.1.2.4.1 Key strengths 223
14.1.2.4.2 Strategic choices 223
14.1.2.4.3 Weaknesses/Competitive threats 224
14.1.3 KONINKLIJKE PHILIPS N.V. 225
14.1.3.1 Business overview 225
14.1.3.2 Products offered 226
14.1.3.3 MnM view 227
14.1.3.3.1 Key strengths 227
14.1.3.3.2 Strategic choices 228
14.1.3.3.3 Weaknesses/Competitive threats 228
14.1.4 GE HEALTHCARE 229
14.1.4.1 Business overview 229
14.1.4.2 Products offered 230
14.1.4.3 Recent developments 231
14.1.4.3.1 Deals 231
14.1.5 MCKESSON CORPORATION 232
14.1.5.1 Business overview 232
14.1.5.2 Products offered 233
14.1.6 B. BRAUN MELSUNGEN AG 234
14.1.6.1 Business overview 234
14.1.6.2 Products offered 236
14.1.7 HALMA PLC 237
14.1.7.1 Business overview 237
14.1.7.2 Products offered 239
14.1.7.3 Recent developments 239
14.1.7.3.1 Expansions 239
14.1.8 OSI SYSTEMS, INC. 240
14.1.8.1 Business overview 240
14.1.8.2 Products offered 241
14.1.8.3 Recent developments 243
14.1.8.3.1 Deals 243
 
14.1.9 AMERICAN DIAGNOSTIC CORPORATION 244
14.1.9.1 Business overview 244
14.1.9.2 Products offered 244
14.1.10 MEDLINE INDUSTRIES, LP. 246
14.1.10.1 Business overview 246
14.1.10.2 Products offered 246
14.1.10.3 Recent developments 248
14.1.10.3.1 Expansions 248
14.1.11 MICROLIFE CORPORATION 249
14.1.11.1 Business overview 249
14.1.11.2 Products offered 249
14.1.12 BIOS MEDICAL 250
14.1.12.1 Business overview 250
14.1.12.2 Products offered 250
14.1.13 ACCOSON 251
14.1.13.1 Business overview 251
14.1.13.2 Products offered 251
14.1.13.3 Recent developments 252
14.1.13.3.1 Deals 252
14.2 OTHER PLAYERS 253
14.2.1 CELLBIOS 253
14.2.2 MIDMARK CORPORATION 254
14.2.3 WITHINGS 255
14.2.4 SPENGLER HOLTEX GROUP 256
14.2.5 BEURER 257
14.2.6 TECHNICUFF 258
14.2.7 W.A. BAUM CO., INC. 259
14.2.8 BPL MEDICAL TECHNOLOGIES 260
14.2.9 BOEN HEALTHCARE CO., LTD 261
14.2.10 MASIMO 262
15 APPENDIX 263
15.1 DISCUSSION GUIDE 263
15.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 267
15.3 CUSTOMIZATION OPTIONS 269
15.4 RELATED REPORTS 269
15.5 AUTHOR DETAILS 270